Severe hypertension development significantly improves progression-free survival in regorafenib treatment for metastatic colorectal cancer

被引：0
|
作者：
Yoshitaka Saito
Yoh Takekuma
Yoshito Komatsu
Mitsuru Sugawara
机构：
[1] Hokkaido University Hospital,Department of Pharmacy
[2] Hokkaido University Hospital,Cancer Center
[3] Hokkaido University,Laboratory of Pharmacokinetics, Faculty of Pharmaceutical Sciences
来源：
International Journal of Clinical Oncology | 2023年 / 28卷
关键词：
Regorafenib; Severe hypertension; Metastatic colorectal cancer (mCRC); Vascular endothelial growth factor (VEGF); Progression-free survival; Multikinase inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1183 / 1190
页数：7
相关论文
共 50 条
  • [31] Development and Validation of a Novel Serum Prognostic Marker for Patients with Metastatic Colorectal Cancer on Regorafenib Treatment
    Su, Yu-Li
    Tsai, Kai-Lung
    Chiu, Tai-Jan
    Lin, Yueh-Ming
    Lee, Ko-Chao
    Lu, Chien-Chang
    Chen, Hong-Hwa
    Wu, Chia-Che
    Hsu, Hung-Chih
    CANCERS, 2021, 13 (20)
  • [32] Chemotherapy Combined With Recombinant Human Endostatin (Endostar) Significantly Improves the Progression-Free Survival of Stage IV Soft Tissue Sarcomas
    Liao, Zhichao
    Zhang, Chao
    Yang, Tielong
    Liu, Haotian
    Yang, Songwei
    Li, Ting
    Xing, Ruwei
    Teng, Sheng
    Yang, Yun
    Zhao, Jun
    Zhao, Gang
    Bai, Xu
    Zhu, Lei
    Yang, Jilong
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [33] Regorafenib as Salvage Treatment in Korean Patients with Refractory Metastatic Colorectal Cancer
    Kim, Seung Tae
    Kim, Tae Won
    Kim, Kyu-Pyo
    Kim, Tae-You
    Han, Sae-Won
    Lee, Ji Yun
    Lim, Sung Hee
    Lee, Min-Young
    Kim, Haesu
    Park, Young Suk
    CANCER RESEARCH AND TREATMENT, 2015, 47 (04): : 790 - 795
  • [34] Progression-free survival as a surrogate endpoint in advanced breast cancer
    Miksad, Rebecca A.
    Zietemann, Vera
    Gothe, Raffaella
    Schwarzer, Ruth
    Conrads-Frank, Annette
    Schnell-Inderst, Petra
    Stollenwerk, Bjoern
    Siebert, Uwe
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2008, 24 (04) : 371 - 383
  • [35] Efficacy and safety of regorafenib in the treatment of metastatic colorectal cancer: A systematic review
    Skarderud, Maria Roed
    Polk, Anne
    Vistisen, Kirsten Kjeldgaard
    Larsen, Finn Ole
    Nielsen, Dorte Lisbet
    CANCER TREATMENT REVIEWS, 2018, 62 : 61 - 73
  • [36] Evaluation of Factors Predicting the Effectiveness of Regorafenib in the Treatment of Metastatic Colorectal Cancer
    Ebinc, Senar
    Oruc, Zeynep
    Urakci, Zuhat
    Kalkan, Ziya
    Kaplan, Muhammet Ali
    Kucukoner, Mehmet
    Isikdogan, Abdurrahman
    EURASIAN JOURNAL OF MEDICINE, 2022, 54 (03) : 229 - 234
  • [37] Toxicities of axitinib, sunitinib and temsirolimus: implications for progression-free and overall survival in metastatic renal cell cancer
    Uhlig, Annemarie
    Uhlig, Johannes
    Trojan, Lutz
    Woike, Michael
    Leitsmann, Marianne
    Strauss, Arne
    FUTURE ONCOLOGY, 2021, 17 (01) : 45 - 56
  • [38] MRI radiomics predicts progression-free survival in prostate cancer
    Jia, Yushan
    Quan, Shuai
    Ren, Jialiang
    Wu, Hui
    Liu, Aishi
    Gao, Yang
    Hao, Fene
    Yang, Zhenxing
    Zhang, Tong
    Hu, He
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [39] The usefulness of progression-free survival in surgical treatment of lung metastases
    Religioni, Jaroslaw
    Rabczenko, Daniel
    Orlowski, Tadeusz
    KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA-POLISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 19 (02) : 75 - 80
  • [40] A Nomogram for Predicting Progression-free Survival in Patients with Endometrial Cancer
    Wang, Z.
    Zhao, Z.
    Li, W.
    Bao, X.
    Liu, T.
    Yang, X.
    CLINICAL ONCOLOGY, 2023, 35 (09) : e516 - e527
12345